莱沃多巴诱导甲状腺功能调节在患有甲状腺激素抵抗和帕金森病的患者:一个病例报告
Gabriela Rozo-Paz1, Clara Maria Ruiz-Forero2, José David Suárez-Mera3
1Universidad de Los Andes, Bogotá, Colombia.
Frontiers in endocrinology
|April 2, 2025
概括
甲状腺激素抵抗 (THR) 是一种罕见的疾病. 这项案例研究突出了勒沃多巴/卡比多巴治疗如何使THR和乳头甲状腺癌患者的甲状腺激素水平正常化.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 甲状腺激素抵抗 (THR) 是一种罕见的遗传综合征,导致对甲状腺激素的敏感性降低.
- 患者经常出现异常的甲状腺功能测试,包括甲状腺激素水平升高而没有足够的TSH反应.
研究的目的:
- 在患有乳头甲状腺癌的患者中报告疑似THR病例.
- 调查莱沃多巴/卡比多巴在THR中控制异常甲状腺激素水平方面的潜在作用.
主要方法:
- 一名经过手术切除的乳头甲状腺癌的55岁女性被评估为疑似THR.
- 为了同时存在的帕金森病,开始接受levodopa/carbidopa治疗.
- 监测了包括TSH和总T3在内的甲状腺功能测试.
主要成果:
- 患者表现出甲状腺激素水平升高,TSH反应不足,符合THR.
- 在接受levodopa/carbidopa治疗后,TSH和总T3水平正常化.
- 这种正常化对于切除残留瘤残余的切除至关重要.
结论:
- 多巴胺影响内分泌系统,特别是甲状腺.
- 莱沃多巴/卡比多巴可能在治疗甲状腺激素抵抗的异常TSH水平方面具有有益作用.
- 这种治疗方法可以在特定的临床场景中帮助平衡甲状腺激素功能.
相关概念视频
Parkinson's Disease: Treatment
162
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
162
Parkinson's Disease: Overview
353
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
353
Synthesis and Regulation of Thyroid Hormones
4.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.0K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Functions of Thyroid Hormones
2.4K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.4K
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


